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a b s t r a c t
In cardiac resynchronization therapy, reaching the target pacing site is essential to achieve
optimal therapy. Coronary vein stenosis in the target vein might be an obstacle for lead
placement, which can be overcome by venoplasty and stenting of the narrowed segment.
Additional active ﬁxation of the left ventricular lead ensures precise location in the target
site with minimal risk of lead dislodgment.
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Targeted pacing site is key in cardiac resynchronization
therapy to achieve reverse left ventricular (LV) remodeling.1
The recently released active ﬁxation LV lead Attain® Stabili-
tyTM (Model 20066, Medtronic Inc, Maastricht, the
Netherlands)2 enables lead placement at the target pacing
site (TPS) with minimal risk of lead displacement. Coronary
veins stenosis may occasionally be encountered, which limits
reaching the TPS. We report a case where a combination of
technologies was mandatory for the procedure success.
2. Case report
We report a case of a male, 64-years-old, with a non-ischemic
cardiomyopathy (no previous myocardial infarction, no* Corresponding author.
E-mail address: matteo.ziacchi@gmail.com (M. Ziacchi).
http://dx.doi.org/10.1016/j.ihj.2015.09.007
0019-4832/# 2015 Cardiological Society of India. Published by Elseviecoronary artery disease), who was reevaluated after 9 months
of optimal medical therapy. He was in NYHA class II and the
ECG (Fig. 1) showed a sinus rhythm with a left bundle branch
block (QRS width = 170 ms). End-diastolic volume was 324 ml,
end-systolic volume was 249 ml, and ejection fraction was 23%
at Echocardiography. The TPS was the mid-apical lateral wall,
as evaluated with strain analysis by speckle tracking. The
venogram, performed during the implant, showed a suitable
lateral vein that matched with the TPS but whose take-off had
an angle >908 with a severe proximal stenosis (Fig. 1, panel A).
A stiff guide-wire was placed distal in the vein, but the stenosis
prevented lead placement into the vein despite the subselector
enabling a strong pushability. We moved to venoplasty, and a
bare metal stent (Taxus Libertè, Boston Scientiﬁc, MN, USA)
was used to treat the stenosis (Fig. 1, panel B).3 The size of the
bare metal stent, related to the size of the vein, was 4 mm of
diameter and 12 mm of length. The inﬂation pressure was
increased up to 14 atm to achieve full stent expansion.r B.V. All rights reserved.
Fig. 1 – Clinical case of venoplasty.
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vein (Fig. 1, panel C), and a quadripolar lead (Quartet left
ventricular lead, St. Jude Medical, MN, USA) was easily put in
place. Electrical delay (Q-LV) was measured in both branches of
the vein, and the ﬁnal location was the most delayed one. The
lead proved to be unstable, showing backward movement in
systole owing to transmission of force along the relatively stiff
lead body; in fact, we observed an acute displacement >1 cm in
a few minutes. This is consistent with a high risk of
dislodgement at follow-up, and we shifted to the active
ﬁxation LV bipolar lead (Fig. 1, panel C) Attain® StabilityTM
(Model 20066, Medtronic Inc, Maastricht, the Netherlands).3
The lead remained stable in the TPS with no phrenic nerve
stimulation, and a stimulation threshold of 0.7 V@0.4 ms when
using the ring electrode as cathodal electrode. The end-
systolic LV volume was decreased by 25% at 6-months follow-
up.
3. Discussion
Reverse LV remodeling is an important goal of CRT because it is
closely associated to outcome.4 The aim of a CRT implant is to
place the LV lead as to achieve reverse remodeling. In this
perspective, any LV lead type or delivery route needs to be
available at minimal risk exposure to the patient: quadripolar,
active ﬁxation, epicardial surgical, or endoventricular lead.2,5,6
After the evaluation of the TPS for the transvenous approach,
coronary veins anatomy becomes fundamental, since at least
one vein leading to TPS needs to be available. Venoplasty is an
option to enable the access to the target vein in the rare event
of coronary vein stenosis, and has been reported to be
successful without adverse events to coronary veins in up to2.5 of patients.7,8 Lead stability at the targeted placement is not
only mandatory to ensure reverse remodeling, but more
importantly to prevent lead dislodgement that may occur in up
to 10% of patients at follow-up3,9 and portends threatened
complications like CIED infection in up to 4% of patients when
a lead repositioning procedure is needed.10 In this perspective,
lead stabilization by any mean has been sought in several
studies2,3,11 with favorable outcome in terms of precise
location and avoidance of phrenic stimulation in the TPS at
minimal risk of lead dislodgement. Though some issues, such
as lead extractability at long term, still need longer follow-up
to be addressed, the early experience shows a very promising
safety proﬁle.3,11
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